{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:35:38Z","timestamp":1780493738867,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.nmd.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:13:24Z","timestamp":1560298404000},"page":"576-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Muscle biopsies in clinical trials for Duchenne muscular dystrophy \u2013 Patients\u2019 and caregivers\u2019 perspective"],"prefix":"10.1016","volume":"29","author":[{"given":"Ingrid E.C.","family":"Verhaart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejal","family":"Thakrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Vroom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke M.","family":"Aartsma-Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik H.","family":"Niks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9307","key":"10.1016\/j.nmd.2019.06.004_bib0001","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.nmd.2019.06.004_bib0002","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.nmd.2019.06.004_bib0003","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nmd.2019.06.004_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-7374-3_1","article-title":"An overview of recent therapeutics advances for Duchenne muscular dystrophy","volume":"1687","author":"Mah","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"10","key":"10.1016\/j.nmd.2019.06.004_bib0005","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol"},{"issue":"9791","key":"10.1016\/j.nmd.2019.06.004_bib0006","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.nmd.2019.06.004_bib0007","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"issue":"26","key":"10.1016\/j.nmd.2019.06.004_bib0008","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.nmd.2019.06.004_bib0009","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne's muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.nmd.2019.06.004_bib0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/acn3.579","article-title":"Placebo-controlled phase 2 trial of drisapersen for Duchenne muscular dystrophy","volume":"5","author":"McDonald","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2019.06.004_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nmd.2017.10.004","article-title":"A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy","volume":"28","author":"Goemans","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"437","key":"10.1016\/j.nmd.2019.06.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.nmd.2019.06.004_bib0013","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.nmd.2019.06.004_bib0014","doi-asserted-by":"crossref","first-page":"e81302","DOI":"10.1371\/journal.pone.0081302","article-title":"Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy","volume":"8","author":"Finkel","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.nmd.2019.06.004_bib0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/mt.2011.237","article-title":"Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector","volume":"20","author":"Bowles","year":"2012","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.nmd.2019.06.004_bib0016","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","article-title":"Histological effects of givinostat in boys with Duchenne muscular dystrophy","volume":"26","author":"Bettica","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2019.06.004_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147634","article-title":"Improved muscle function in Duchenne muscular dystrophy through l-arginine and metformin: an investigator-initiated, open-label, single-center, proof-of-concept-study","volume":"11","author":"Hafner","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.nmd.2019.06.004_bib0018","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","article-title":"A phase I\/IItrial of MYO-029 in adult subjects with muscular dystrophy","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2019.06.004_bib0019","unstructured":"U.S. Food&Drug Administration. FDA grants accelerated approval to first drug for Duchenne muscular dystrophy2016[updated September 19, 2016. Available from:https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm521263.htm."},{"issue":"5","key":"10.1016\/j.nmd.2019.06.004_bib0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/sms.12808","article-title":"The muscle biopsy technique. Historical and methodological considerations","volume":"27","author":"Ekblom","year":"2017","journal-title":"Scand J Med Sci Sports"},{"issue":"7","key":"10.1016\/j.nmd.2019.06.004_bib0021","first-page":"1591","article-title":"Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool","volume":"28","author":"Dorph","year":"2001","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.nmd.2019.06.004_bib0022","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.nmd.2018.05.013","article-title":"Report on the workshop: meaningful outcome measures for Duchenne muscular dystrophy, London, UK, 30-31 January 2017","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul Disord."},{"issue":"2","key":"10.1016\/j.nmd.2019.06.004_bib0023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1460-9592.2007.02302.x","article-title":"Duchenne muscular dystrophy: an old anesthesia problem revisited","volume":"18","author":"Hayes","year":"2008","journal-title":"Paediatr Anaesth"},{"issue":"9","key":"10.1016\/j.nmd.2019.06.004_bib0024","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/pan.12248","article-title":"Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures","volume":"23","author":"Segura","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.nmd.2019.06.004_bib0025","unstructured":"M\u00fcnster T.Orphan Anesthesia: anaesthesia recommendations for patients suffering from Duchenne muscular dystrophy[updated June 2011. Available from:https:\/\/www.orpha.net\/data\/patho\/Pro\/en\/Duchenne_EN.pdf."},{"issue":"1","key":"10.1016\/j.nmd.2019.06.004_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nmd.2017.10.002","article-title":"Workshop p. 226(th) ENMC International Workshop: towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, the Netherlands","volume":"28","author":"Aartsma-Rus","year":"2018","journal-title":"Neuromuscul Disord."},{"issue":"1","key":"10.1016\/j.nmd.2019.06.004_bib0027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/nat.2018.0756","article-title":"A sequel to the eteplirsen Saga: eteplirsen is approved in the United States but was not approved in Europe","volume":"29","author":"Aartsma-Rus","year":"2019","journal-title":"Nucleic Acid Ther"},{"issue":"3","key":"10.1016\/j.nmd.2019.06.004_bib0028","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/gt.2009.145","article-title":"Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes","volume":"17","author":"Ferlini","year":"2010","journal-title":"Gene Ther"},{"issue":"6","key":"10.1016\/j.nmd.2019.06.004_bib0029","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/mt.2010.72","article-title":"Preclinical PK and PD studies on 2\u2032-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model","volume":"18","author":"Heemskerk","year":"2010","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.nmd.2019.06.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195850","article-title":"Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy","volume":"13","author":"Beekman","year":"2018","journal-title":"PLoS ONE"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619302196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619302196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:08:21Z","timestamp":1760774901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896619302196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0960896619302196"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2019.06.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle biopsies in clinical trials for Duchenne muscular dystrophy \u2013 Patients\u2019 and caregivers\u2019 perspective","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}